How subtle differences in polymer molecular weight affect doxorubicin-loaded PLGA nanoparticles degradation and drug release-Reference-Cited by-同舟云学术

How subtle differences in polymer molecular weight affect doxorubicin-loaded PLGA nanoparticles degradation and drug release

Published:2020-02-20 Issue:3 Volume:37 Page:283-295
ISSN:0265-2048
Container-title:Journal of Microencapsulation
language:en
Short-container-title:Journal of Microencapsulation

Author:

Kumskova Natalya¹,Ermolenko Yulia¹²,Osipova Nadezhda¹²,Semyonkin Aleksey¹³,Kildeeva Natalia⁴,Gorshkova Marina⁵,Kovalskii Andrey⁶,Kovshova Tatyana¹⁷,Tarasov Vadim³,Kreuter Joerg³⁸,Maksimenko Olga¹²,Gelperina Svetlana¹²

Affiliation:

1. D. Mendeleev University of Chemical Technology of Russia, Moscow, Russia;

2. Drugs Technology LLC, Khimki, Russia;

3. I. M. Sechenov First Moscow State Medical University, Moscow, Russia;

4. A. N. Kosygin Russian State University, Moscow, Russia;

5. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences, Moscow, Russia;

6. National University of Science and Technology “MISIS”, Moscow, Russia;

7. Lomonosov Moscow State University, Moscow, Russia;

8. Institute of Pharmaceutical Technology, Biocenter Niederursel, Goethe University, Frankfurt/Main, Germany

Publisher

Informa UK Limited

Subject

Colloid and Surface Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Pharmaceutical Science,Bioengineering

Link

https://www.tandfonline.com/doi/pdf/10.1080/02652048.2020.1729885

Reference36 articles.

1. Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]

2. Analysis of initial burst in PLGA microparticles

3. Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres

4. Can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges

5. Molecular weight distribution changes during degradation and release of PLGA nanoparticles containing epirubicin HCl

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Process Parameters for Controlled Drug Delivery: A Quality by Design (QbD) Approach in Naltrexone Microspheres;AAPS PharmSciTech;2024-05-09

2. Studying the stability of polymer nanoparticles by size exclusion chromatography of radioactive polymers;Journal of Controlled Release;2024-05

3. Poly(D,l-lactide-co-glycolide) particles are metabolised by the gut microbiome and elevate short chain fatty acids;Journal of Controlled Release;2024-05

4. Increased reactive carboxyl and free alfa-amino groups from fish type I collagen peptides by Alcalase^® hydrolysis exhibit higher antibacterial and antioxidant activities;International Journal of Food Engineering;2024-03-20

5. Immune Potentiation of PLGA Controlled-Release Vaccines for Improved Immunological Outcomes;ACS Omega;2024-02-28